Cannabis Law Report

JUNE 7, 2021

Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Industry Developments.

Research and Development 98

Research and Development Clinical Trials Extraction Retail 98

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

JULY 24, 2021

At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. “At At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

AUGUST 9, 2021

Investors will continue to keep an eye on several ongoing clinical trials, as well as private companies that are gearing up to go public over the coming quarters. OTC: WUHN) recently announced that a research team funded by the company successfully published a third paper on the Dovepress platform. Industry Developments.

Clinical Trials 105

Clinical Trials Decriminalization Research and Development Treatment 105

Cannabis Law Report

JUNE 20, 2021

LeafCann ’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production, and GMP manufacturing.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Cannabis Law Report

JANUARY 12, 2022

The sale will accelerate the development of Gb Sciences’ proprietary Parkinson’s disease and COVID-related Cytokine-Release Syndrome therapies. “We have emerged from this sale as a pure-play biopharmaceutical research and development company. LAS VEGAS, Jan. 11, 2022 (GLOBE NEWSWIRE) — Gb Sciences, Inc.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

MARCH 18, 2020

The company, a leader in hemp-derived CBD extract products, has created an internal research and development division led by a former healthcare executive to focus on the science of hemp-derived phytocannabinoids, terpenes and flavonoid compounds. Charlotte’s Web Holdings, Inc. Source: [link].

Clinical Trials 59

Clinical Trials Research and Development Terpenes Hemp 59

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

JUNE 15, 2022

Materia is one of many other operators that have recently established a headquarters in Malta since the legislation permitting the production of medical cannabis products for research and medical purposes was enacted in 2018. Malta is an ideal testbed for research given its small size and business-friendly approach.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

The Cannigma

DECEMBER 14, 2021

HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant. The importance of this finding is that, similar to CBN, HHC may occur naturally as a degradation product in aged cannabis, extracts, and concentrates. Hexahydrocannabinol (HHC). What is hydrogenation?

Research and Development 116

Research and Development Cannabinoids Clinical Trials THC 116

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

SEPTEMBER 12, 2022

This yield gives us the capacity and scale we need to advance our analytical schedule while also developing our product pipeline,” he added. Optimi will also be using the mushrooms to further develop its on-site extraction methods and will use the product to finalize its naturally derived psilocybin offerings this fall.

History 52

History Clinical Trials Legalization Research and Development 52

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For example, research shows that primary care physicians misdiagnosed 65.9% Mental Health Challenges. Psychedelics Provide a Solution.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

The Cannigma

JUNE 23, 2022

And while there is essentially no research to say what CBGA does when taken by humans, CBGA has undergone preliminary (preclinical) research for its effects in seizures, inflammation, diabetes, and even COVID infections. Pain and inflammation. More studies are needed to fully understand CBGA’s application in inflammation.

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Veriheal

NOVEMBER 17, 2020

But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision. ” One Ohio Physician Embraces Cannabis Research But Denies Effectiveness . Research Shows to be Supportive Despite it All.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.”

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

JUNE 11, 2021

Over the past months, Mydecine’s research and development teams have screened over 25 mushroom species, including various varieties of p. We have seen accelerated progress through Mydecine’s fully integrated research and cultivation facilities,” stated Josh Bartch, CEO of Mydecine. About Mydecine Innovations Group.

Research and Development 59

Research and Development Clinical Trials Therapy Pharmaceutical 59

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The research we completed is exploratory but the results are consistent with our earlier research. “The We look forward to the next chapters in their development”.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

MMJ Recs

JULY 11, 2020

An alarmingly high number of deaths in many countries has led to researchers scrambling to find an effective treatment or cure for the disease. The Canadian study examined the connection between hemp extracts high in CBD and whether they could help block proteins that allow COVID-19 to enter host cells. Featured image by Adam Nie?cioruk

Research and Development 52

Research and Development Treatment Clinical Trials Therapy 52

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! government classified all cannabis varieties, including hemp, as Schedule I under the Controlled Substances Act (despite decades of agricultural research detailing its differences from marijuana). What makes CBD special? In 1970, the U.S. What can CBD do?

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

APRIL 1, 2019

Selling dried cannabis to pharmaceutical companies as well as Cannabidiol (CBD) and Tetrahydrocannabinol (THC) extracts as soon as it is licensed, is the intention of Thailand’s tobacco authority among new measures to turn a profit on its dwindling cigarette business. The existing commercial infrastructure of both organizations is large.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Cannabis Law Report

SEPTEMBER 3, 2019

Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

SEPTEMBER 8, 2021

Epsilon’s Southport Facility is the largest cannabis extraction facility in the Southern Hemisphere with TGA and EU GMP capability. THC Pharma’s GMP Southport facility is a 10,000 square foot purpose-built botanicals extraction facility capable of extraction of raw plant material and downstream purification and isolation processing.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

FEBRUARY 3, 2022

The smoke is released by heating cannabis leaves, extracts with psychoactive chemicals. Oils extracted from cannabis have various benefits and advantages in medical, food & beverage, and personal care industries. Product Development Via Research and Novel Product Delivery Solutions. Opportunities. Challenges.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

NOVEMBER 29, 2019

Preliminary research has also shown that CBD has the potential to help patients with Parkinson’s and Alzheimer’s diseases. However, researchers have shown other potential health applications of cannabis and THC. For instance, the study showed a link between cannabis use and schizophrenia development. THC Oil Effects.

Oil 104

Oil THC Cannabinoids Research and Development 104

The Joint Blog

MARCH 18, 2021

The study is published in the Journal of Basic and Clinical Physiology and Pharmacology and was epublished by the National Institute of Health. For the study researchers examined data published within the past ten years assessing the use of cannabinoids in patients with PTS.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

Cannabis Law Report

DECEMBER 11, 2021

These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. “Our plan is to open more cannabis clinics to cover most of the tambons across the nation,” Dr Kwanchai said.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

DECEMBER 7, 2021

In conclusion, cannabidiol is associated with clinical improvement in Dravet syndrome. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. Data extraction. However, cannabidiol is also associated with decreased appetite. Introduction. Adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. There is no signal for the development of substance use disorder in individuals consuming CBD-containing products.”. “It

Hemp 49

Hemp CBD Law Seed-To-Sale 49

The Cannigma

OCTOBER 27, 2021

These findings were unearthed in a study titled “Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys,” carried out at the Mason Research Institute in Worcester Massachusetts in 1973. The study compared herculean doses of delta-8 THC to delta-9 THC, and a crude marijuana extract (CME), which is something similar to RSO.

THC 144

THC Research and Development Clinical Trials Cannabinoids 144

Cannabis Law Report

APRIL 8, 2019

The Commonwealth Parliament’s legislation is in line with a trend towards medicinal legalisation across the developed world in recognition of a growing medical consensus concerning the therapeutic role that “cannabinoids” (chemical compounds derived from plants of the genus cannabis) can play in treating disease and illness.

Medicine 71

Medicine Research and Development Business Cannabis 71